InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Wednesday, 09/11/2019 1:30:20 PM

Wednesday, September 11, 2019 1:30:20 PM

Post# of 8287
News: $SPEX Spherix is Granted Exclusive Option to License Anticancer Drug from the University of Kentucky

NEW YORK , Sept. 11, 2019 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced that the Company has executed an exclusive option agreement ("Option") with the University of Kentucky (UK) related to its anticancer drug designated G4-1, a novel proteasome inhibitor. ...

Find out more SPEX - Spherix is Granted Exclusive Option to License Anticancer Drug from the University of Kentucky